Harmonized Tariff Schedule of the U.S. › Chapter 30 Pharmaceutical products
3002.14.00.10Tariff line
Classification path
Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified
3002
Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes
Immunological products, mixed, not put up in measured doses or in forms or packings for retail sale
Containing monoclonal antibodies
3002.14.00.10
Rates of duty
General rate (Column 1)Free
Special—
Column 2Free
Unitkg
Printed page 1583
Measure flags
for origin CN, entry date 2026-10-25 · base rate Free
- Section 301 forced-labor tariff (12.5%)9903.05.86ExemptexemptOn the note 52(b) general exemption list (exempt by HTS line; enter under 9903.05.86)
- China 301: not on any listN/A—8-digit subheading 3002.14.00 is not on Lists 1–4B or the four-year-review lists
- 232 patented pharmaceuticals9903.04.60Conditionalcapped at 100%General (all other countries) | Pharmaceutical articles (chapter 30): patented finished drugs / APIs / key starting materials; patented or generic status is determined by the article, not by t
- PGAFDA FD1APHIS Core AQ1
Confirmed total 0% · max 100%Full duty breakdown →